Probable autoimmune lymphoproliferative syndrome with monogenic lupus due to KRAS mutation - A rare encounter
Main Article Content
Keywords
autoimmune lymphoprolifearive syndrome, monogenic lupus, KRAS, RAS associated leukoproliferative disorder
Abstract
Autoimmune lymphoproliferative syndrome (ALPS) is a disease characterized by dysfunction of the T lymphocyte apoptotic pathways, mostly due to dysfunctional FAS mediated signaling. However few cases can also occur independent of FAS pathway alteration. ALPS is characterized by various immuno-hematological manifestations. Monogenic lupus is an evolving entity, which describes the etiologic role of single gene modulation in systemic lupus erythematosus. In this manuscript, we describe a case of probable ALPS with monogenic lupus caused by a novel mutation in the KRAS gene.
Downloads
Abstract 137
PDF Downloads 166
HTML Downloads 12
References
2. Oliveira, Joao B et al. “Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.” Blood vol. 116,14 (2010): e35-40. doi:10.1182/blood-2010-04-280347
3. Neven, Quentin et al. “Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD).” Journal of clinical immunology vol. 41,1 (2021): 51-58. doi:10.1007/s10875-020-00883-7
4. Masatoshi Takagi, Kunihiro Shinoda, Jinhua Piao, Noriko Mitsuiki, Mari Takagi, Kazuyuki Matsuda, Hideki Muramatsu, Sayoko Doisaki, Masayuki Nagasawa, Tomohiro Morio, Yoshihito Kasahara, Kenichi Koike, Seiji Kojima, Akira Takao, Shuki Mizutani; Autoimmune lymphoproliferative syndrome–like disease with somatic KRAS mutation. Blood 2011; 117 (10): 2887–2890
5. Alperin JM, Ortiz-Fernández L and Sawalha AH (2018) Monogenic Lupus: A Developing Paradigm of Disease. Front. Immunol. 9:2496. doi: 10.3389/fimmu.2018.02496
6. Webb R, Kelly JA, Somers EC, Hughes T, Kaufman KM, Sanchez E, et al. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Ann Rheum Dis. (2011) 70:151–6. doi: 10.1136/ard.2010.141697
7. .E. Niemela, L. Lu, T.A. Fleisher, J. Davis, I. Caminha, M. Natter, L.A. Beer, K.C. Dowdell, S. Pittaluga, M. Raffeld, V.K. Rao, J.B. Oliveira, Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis, Blood 117 (2011) 2883–2886.
8. Ragotte RJ, Dhanrajani A, Pleydell-Pearce J, Del Bel KL, TarailoGraovac M, van Karnebeek C, et al. The importance of considering monogenic causes of autoimmunity: a somatic mutation in KRAS causing pediatric Rosai-Dorfman syndrome and systemic lupus erythematosus. Clin Immunol. 2017;175:143–6
9. Huang, Lamei et al. “KRAS mutation: from undruggable to druggable in cancer.” Signal transduction and targeted therapy vol. 6,1 386. 15 Nov. 2021, doi:10.1038/s41392-021-00780-4
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.